UK markets close in 2 hours 26 minutes
  • FTSE 100

    7,497.67
    +8.48 (+0.11%)
     
  • FTSE 250

    18,947.56
    +16.99 (+0.09%)
     
  • AIM

    832.61
    -1.92 (-0.23%)
     
  • GBP/EUR

    1.1606
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2226
    +0.0021 (+0.17%)
     
  • BTC-GBP

    13,791.46
    -70.18 (-0.51%)
     
  • CMC Crypto 200

    396.65
    -5.38 (-1.34%)
     
  • S&P 500

    3,933.92
    -7.34 (-0.19%)
     
  • DOW

    33,597.92
    +1.58 (+0.00%)
     
  • CRUDE OIL

    74.98
    +2.97 (+4.12%)
     
  • GOLD FUTURES

    1,801.20
    +3.20 (+0.18%)
     
  • NIKKEI 225

    27,574.43
    -111.97 (-0.40%)
     
  • HANG SENG

    19,450.23
    +635.41 (+3.38%)
     
  • DAX

    14,241.45
    -19.74 (-0.14%)
     
  • CAC 40

    6,657.67
    -2.92 (-0.04%)
     

Olink to participate in November investor events

Olink Proteomics AB
Olink Proteomics AB

UPPSALA, Sweden, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events:

  • Olink Investor Day 2022
    Monday, November 14th at 11:00 am ET

  • Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    Thursday, November 17th at 2:00 pm ET

A live and archived webcast of the Olink Investor Day will be available on the “Events” section of the Company’s website at https://investors.olink.com/news-events/events.

About Olink
Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

IR contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Media contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com